The Once-Daily PAH Treatment
ADCIRCA (pronounced AD-SUR-KUH) is a prescription medicine called a phosphodiesterase 5 inhibitor (PDE-5i) used to treat pulmonary arterial hypertension (PAH, high blood pressure in your lungs) to improve exercise ability.
Patients taking ADCIRCA increased their 6-minute walk distance by an average of 33 meters (108 feet) after 16 weeks of treatment.
Learn More
What is PAH?
PAH is high blood pressure in the blood vessels of the lungs, which is different than ordinary high blood pressure that can occur throughout the body.
What is PAHFor answers to common questions about ADCIRCA
The most common side effects of ADCIRCA are headache, muscle pain, getting red or hot in the face (flushing), nausea, pain in the arms, legs or back, upset stomach, and stuffy or congested nose.
These are not all the possible side effects of ADCIRCA. For more information, ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.
ADCIRCA contains tadalafil, the same main ingredient in Cialis®:
- Active ingredient: tadalafil
- Inactive ingredients: croscarmellose sodium, hydroxypropyl cellulose, hypromellose, iron oxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, talc, titanium dioxide, and triacetin
Resources
Here you will find additional resources on pulmonary arterial hypertension (PAH), including PAH organizations and community groups, and downloadable resources to support your treatment with ADCIRCA.